secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001213900-25-006526
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics regains Nasdaq compliance on minimum bid price requirement
----------------------------------------------------------------------------

- Received Nasdaq notice on Jan 23, 2025 that stock closed at or above $1.00 for 10 consecutive business days (Jan 7-22, 2025).
- Compliance with Nasdaq Listing Rule 5550(a)(2) achieved; delisting matter closed.
- CEO Robb Knie said milestone reinforces commitment to long-term shareholder value.
- Company continues advancing its biopharmaceutical pipeline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390025006526/0001213900-25-006526-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390025006526/ea0228609-8k_hoth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-006526

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer